Fundraising Fox

Dementia Discovery Fund

Venture capital

London · Seed–Series A · 80 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

SV Health Investors is a healthcare-focused investment firm managing multiple funds across therapeutics, biotech, healthcare growth and medtech, including the Dementia Discovery Fund.

Invests inBiotechDigital HealthHealthtechIoTMedical DevicesEuropeLondonUnited KingdomUnited States

Source: firm website, verified Jul 30, 2026.

Stage
Seed–Series A
HQ
London, GB
Instruments
Equity
Tracked investments
1

Team · 80 people

from the firm's website
A.J. Rossi· Partner
Christian Jung· Partner
Greg Madden· Managing Partner
Jamil M. Beg· Partner
Kate Bingham· Managing Partner

Managing Partner at SV Health Investors and chair of Alchemab's board of directors.

Laurence Barker· Partner
Michael Balmuth· Managing Partner
Mike Ross· Senior Partner
Miles Gerson· Partner
Nikola Trbovic· Managing Partner
Paul LaViolette· Managing Partner
Tom Flynn· Managing Partner
Charles Dunn· Principal
Dirk Landgraf· Principal
Barbara Tate· Venture Partner
Brett Haumann· Venture Partner
Charles Large· Venture Partner
Damian Crowther· Venture Partner
David Guyer· Venture Partner
David Reynolds· Venture Partner
Iain Kilty· Venture Partner
James Summers· Venture Partner
Jane Osbourn· Venture Partner
Joanna Wolak· Venture Partner
Kevin Pojasek· Venture Partner
Luke Devey· Venture Partner
Lynne Hughes· Venture Partner
Michael Hutton· Venture Partner
Neil Weir· Venture Partner
Ravi Rao· Venture Partner
Ray Jupp· Venture Partner
Susan Hill· Venture Partner
Tetsu Maruyama· Venture Partner
Alex Badamchi-Zadeh· Vice President
Ali Jazayeri· Operating Partner
Andrew Cappetta· Vice President
Anne Phelan· DDF SAB Member
Anne-Marie Garraway· Executive Assistant
Ashley Pulcini· Executive Assistant
Brent Faduski· Chief Financial Officer, Chief Compliance Officer and Partner
Bryce Hewitt· Finance Associate
Celina Lee· Gradiant in Residence
Ceri Davies· DDF SAB Member
Dan Burgess· Operating Partner
Darshi Singh· Head of IT
Eugene Hill· Chairman
Fiona Elwood· DDF SAB Member
Georgia Frost· Vice President
Georgina Ewels· Director, Investor Relations
Gloria Lau· Junior Fund Controller
Greg Dulgarian· Controller
Hannah Maunder· Senior Associate, Investor Relations
Inna Walker· Business Support and Office Coordinator
James Costine· Chief Financial Officer (UK) and Partner
Jean Rivera Irizarry· Associate
Jodie O'Neill· Accountant
John Lyons· DDF SAB Member
Jonathan Mott· Chief Compliance Officer
Kate McCabe· Finance Director
Kelly DeKeyser· Executive in Residence
Kerry Spellman· Executive Assistant
Lennart Spindler· Associate
Luke Johnson· Operating Partner
Maria Carrillo· DDF SAB Member
Michael Heneka· Scientific Advisor
Michael Ugwueke· President & CEO, Methodist Le Bonheur Healthcare (Growth Fund Advisory Board)
Nicole Cox· Executive Assistant
Nikki Hecht· Executive Assistant
Niranjan Bose· DDF SAB Member
Pam Simpkins· Growth Fund Advisory Board
Rana Al-Hallaq· DDF SAB Member
Richard Hargreaves· DDF SAB Member
Roopam Chandaria· Financial Controller
Ruth McKernan· Operating Partner
Stacey Jolin· Executive Assistant
Susan Kohlhaas· DDF SAB Member
Tim Harris· Operating Partner
Tom Patton· Operating Partner
Tom Policelli· Executive in Residence
Vineela Kanagala· Senior Associate

Investments · 1 tracked

founders shown can be your intro path

Frequently asked questions

What stage does Dementia Discovery Fund invest at?
Dementia Discovery Fund invests at the Seed, Series A stages.
What sectors does Dementia Discovery Fund focus on?
Dementia Discovery Fund focuses on Biotech, Digital Health, Healthtech, IoT, Medical Devices.
Where is Dementia Discovery Fund located?
Dementia Discovery Fund is headquartered in London, GB.

Similar investors

Featured in lists